These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30868284)

  • 21. GASTRIC NEUROENDOCRINE TUMOR: REVIEW AND UPDATE.
    Dias AR; Azevedo BC; Alban LBV; Yagi OK; Ramos MFKP; Jacob CE; Barchi LC; Cecconello I; Ribeiro U; Zilberstein B
    Arq Bras Cir Dig; 2017; 30(2):150-154. PubMed ID: 29257854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
    Lloyd KA; Parsons BN; Burkitt MD; Moore AR; Papoutsopoulou S; Boyce M; Duckworth CA; Exarchou K; Howes N; Rainbow L; Fang Y; Oxvig C; Dodd S; Varro A; Hall N; Pritchard DM
    Cell Mol Gastroenterol Hepatol; 2020; 10(1):113-132. PubMed ID: 32004755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.
    Min BH; Hong M; Lee JH; Rhee PL; Sohn TS; Kim S; Kim KM; Kim JJ
    Br J Surg; 2018 Oct; 105(11):1480-1486. PubMed ID: 29893418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gastric neuroendocrine tumors. Endoscopic and surgical treatment].
    Niederle MB; Niederle B
    Chirurg; 2011 Jul; 82(7):574-82. PubMed ID: 21691871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gastric neuroendocrine tumors].
    Louthan O
    Vnitr Lek; 2009 Oct; 55(10):961-6. PubMed ID: 19947241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of laparoscope-assisted antrectomy for gastric carcinoids with hypergastrinemia.
    Hoshino M; Omura N; Yano F; Tsuboi K; Matsumoto A; Yamamoto SR; Akimoto S; Kashiwagi H; Yanaga K
    Hepatogastroenterology; 2010; 57(98):379-82. PubMed ID: 20583448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric Carcinoids.
    Grozinsky-Glasberg S; Alexandraki KI; Angelousi A; Chatzellis E; Sougioultzis S; Kaltsas G
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):645-660. PubMed ID: 30098721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of Gastric NETs: Role of Gastrin and Menin.
    Sundaresan S; Kang AJ; Merchant JL
    Curr Gastroenterol Rep; 2017 Jul; 19(7):32. PubMed ID: 28608155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuroendocrine tumors of the stomach. Risk stratification and therapy].
    Klöppel G; Scherübl H
    Pathologe; 2010 May; 31(3):182-7. PubMed ID: 20306044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A knockin mouse model for human ATP4aR703C mutation identified in familial gastric neuroendocrine tumors recapitulates the premalignant condition of the human disease and suggests new therapeutic strategies.
    Calvete O; Varro A; Pritchard DM; Barroso A; Oteo M; Morcillo MÁ; Vargiu P; Dodd S; Garcia M; Reyes J; Ortega S; Benitez J
    Dis Model Mech; 2016 Sep; 9(9):975-84. PubMed ID: 27491072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study.
    Chen YY; Guo WJ; Shi YF; Su F; Yu FH; Chen RA; Wang C; Liu JX; Luo J; Tan HY
    BMC Gastroenterol; 2023 Dec; 23(1):440. PubMed ID: 38097952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features of primary gastric neuroendocrine neoplasms: A single-center analysis.
    Xu TM; Wang CS; Jia CW; Qian JM; Li JN
    J Dig Dis; 2016 Mar; 17(3):162-8. PubMed ID: 26860897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of multicentric gastric carcinoids without hypergastrinemia.
    Moriyama T; Matsumoto T; Hizawa K; Esaki M; Lwai K; Yao T; Iida M
    Endoscopy; 2003 Jan; 35(1):86-8. PubMed ID: 12510233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modern Management of Gastric Neuroendocrine Neoplasms.
    Kunstman JW; Nagar A; Gibson J; Kunz PL
    Curr Treat Options Oncol; 2024 Sep; 25(9):1137-1152. PubMed ID: 39083164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypergastrinemia, type 1 gastric carcinoid tumors: diagnosis and management.
    Hung OY; Maithel SK; Willingham FF; Farris AB; Kauh JS
    J Clin Oncol; 2011 Sep; 29(25):e713-5. PubMed ID: 21747088
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy.
    Eltawil KM; Gustafsson BI; Kidd M; Modlin IM
    J Clin Gastroenterol; 2010; 44(10):687-95. PubMed ID: 20375728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease: Commentary.
    Iyer R; Hatoum H
    Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 7):17-9. PubMed ID: 27168109
    [No Abstract]   [Full Text] [Related]  

  • 38. Gastroenteropancreatic Neuroendocrine Tumors.
    Cives M; Strosberg JR
    CA Cancer J Clin; 2018 Nov; 68(6):471-487. PubMed ID: 30295930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric Neuroendocrine Tumors (G-Nets): Incidence, Prognosis and Recent Trend Toward Improved Survival.
    Yang Z; Wang W; Lu J; Pan G; Pan Z; Chen Q; Liu W; Zhao Y
    Cell Physiol Biochem; 2018; 45(1):389-396. PubMed ID: 29402806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
    Wolin EM
    Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.